Concepts (161)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Hypertension, Pulmonary | 6 | 2022 | 1484 | 1.110 |
Why?
|
Pulmonary Embolism | 4 | 2021 | 2367 | 0.830 |
Why?
|
Pulmonary Circulation | 1 | 2021 | 738 | 0.690 |
Why?
|
Wounds, Gunshot | 2 | 2019 | 532 | 0.600 |
Why?
|
Adaptor Proteins, Signal Transducing | 3 | 2021 | 3032 | 0.550 |
Why?
|
Aftercare | 1 | 2020 | 672 | 0.550 |
Why?
|
Thromboembolism | 1 | 2021 | 986 | 0.550 |
Why?
|
Cell Adhesion | 1 | 2021 | 3323 | 0.510 |
Why?
|
Calcitonin | 1 | 2015 | 350 | 0.510 |
Why?
|
Pneumonia, Bacterial | 1 | 2015 | 315 | 0.450 |
Why?
|
Protein Precursors | 1 | 2015 | 1200 | 0.410 |
Why?
|
Computer Simulation | 2 | 2014 | 6059 | 0.390 |
Why?
|
Pulmonary Wedge Pressure | 2 | 2022 | 275 | 0.390 |
Why?
|
Computer-Assisted Instruction | 1 | 2013 | 384 | 0.390 |
Why?
|
Health Status Disparities | 1 | 2020 | 1723 | 0.350 |
Why?
|
Dyspnea | 2 | 2016 | 1238 | 0.350 |
Why?
|
Critical Illness | 1 | 2020 | 2471 | 0.330 |
Why?
|
Coronavirus Infections | 3 | 2020 | 3163 | 0.330 |
Why?
|
Pneumonia, Viral | 3 | 2020 | 3276 | 0.330 |
Why?
|
Critical Care | 1 | 2020 | 2490 | 0.330 |
Why?
|
Vascular Resistance | 2 | 2020 | 959 | 0.310 |
Why?
|
Faculty, Medical | 1 | 2013 | 1158 | 0.270 |
Why?
|
Healthcare Disparities | 1 | 2020 | 2987 | 0.270 |
Why?
|
Endothelial Cells | 4 | 2021 | 3398 | 0.260 |
Why?
|
Internal Medicine | 3 | 2017 | 999 | 0.260 |
Why?
|
Health Services Accessibility | 1 | 2020 | 4996 | 0.240 |
Why?
|
Education, Medical | 1 | 2014 | 1686 | 0.230 |
Why?
|
Mental Disorders | 1 | 2020 | 6463 | 0.200 |
Why?
|
Internship and Residency | 3 | 2017 | 5527 | 0.200 |
Why?
|
Methamphetamine | 1 | 2021 | 130 | 0.200 |
Why?
|
Ultrasonography | 1 | 2013 | 5913 | 0.200 |
Why?
|
Lung | 5 | 2022 | 9617 | 0.180 |
Why?
|
Signal Transduction | 3 | 2021 | 23985 | 0.180 |
Why?
|
Cough | 1 | 2022 | 550 | 0.180 |
Why?
|
Pulmonary Medicine | 1 | 2020 | 215 | 0.170 |
Why?
|
Collagen Type III | 1 | 2018 | 90 | 0.170 |
Why?
|
Facial Injuries | 1 | 2018 | 186 | 0.160 |
Why?
|
Advisory Committees | 1 | 2020 | 757 | 0.150 |
Why?
|
Emergency Service, Hospital | 1 | 2015 | 7410 | 0.140 |
Why?
|
Ventricular Function, Right | 1 | 2019 | 579 | 0.140 |
Why?
|
Fibrosis | 2 | 2021 | 1922 | 0.140 |
Why?
|
Consensus | 2 | 2022 | 2668 | 0.140 |
Why?
|
Vulnerable Populations | 1 | 2020 | 652 | 0.140 |
Why?
|
Microvessels | 1 | 2019 | 560 | 0.130 |
Why?
|
Models, Animal | 1 | 2021 | 2218 | 0.130 |
Why?
|
Vascular Diseases | 1 | 2022 | 1152 | 0.130 |
Why?
|
Foramen Ovale, Patent | 1 | 2016 | 209 | 0.130 |
Why?
|
Calcitonin Gene-Related Peptide | 1 | 2015 | 273 | 0.120 |
Why?
|
International Cooperation | 1 | 2020 | 1454 | 0.120 |
Why?
|
Clinical Competence | 4 | 2020 | 4618 | 0.120 |
Why?
|
Minority Groups | 1 | 2020 | 1064 | 0.120 |
Why?
|
Cell Separation | 1 | 2019 | 1856 | 0.120 |
Why?
|
Educational Measurement | 2 | 2017 | 1272 | 0.120 |
Why?
|
Central Nervous System Stimulants | 1 | 2021 | 1234 | 0.120 |
Why?
|
Paracentesis | 1 | 2012 | 95 | 0.120 |
Why?
|
Exercise Tolerance | 1 | 2018 | 795 | 0.110 |
Why?
|
Lung Diseases | 1 | 2022 | 1890 | 0.110 |
Why?
|
Firearms | 1 | 2018 | 549 | 0.110 |
Why?
|
Humans | 26 | 2022 | 709431 | 0.100 |
Why?
|
Pneumonia | 1 | 2022 | 2071 | 0.100 |
Why?
|
Ascites | 1 | 2012 | 344 | 0.100 |
Why?
|
Problem-Based Learning | 1 | 2014 | 338 | 0.100 |
Why?
|
Gastroenteritis | 1 | 2012 | 259 | 0.100 |
Why?
|
Blood Platelets | 1 | 2021 | 2481 | 0.100 |
Why?
|
Suicide, Attempted | 1 | 2018 | 1138 | 0.100 |
Why?
|
Biocompatible Materials | 1 | 2019 | 1722 | 0.100 |
Why?
|
Single-Cell Analysis | 1 | 2021 | 2167 | 0.100 |
Why?
|
Glypicans | 1 | 2009 | 26 | 0.100 |
Why?
|
Survivors | 1 | 2020 | 2141 | 0.100 |
Why?
|
Venous Thrombosis | 1 | 2018 | 1229 | 0.090 |
Why?
|
Hospitals, Teaching | 1 | 2013 | 1157 | 0.090 |
Why?
|
Eosinophilia | 1 | 2012 | 515 | 0.090 |
Why?
|
Phosphoproteins | 1 | 2018 | 2574 | 0.090 |
Why?
|
Chronic Disease | 2 | 2021 | 9011 | 0.090 |
Why?
|
Patient Care Team | 1 | 2020 | 2596 | 0.090 |
Why?
|
Societies, Medical | 1 | 2020 | 3665 | 0.090 |
Why?
|
Opioid-Related Disorders | 1 | 2021 | 1825 | 0.080 |
Why?
|
Male | 15 | 2022 | 351848 | 0.080 |
Why?
|
Teaching | 1 | 2015 | 1193 | 0.080 |
Why?
|
Endoscopy, Gastrointestinal | 1 | 2012 | 757 | 0.080 |
Why?
|
Postpartum Period | 1 | 2012 | 958 | 0.080 |
Why?
|
Pandemics | 3 | 2020 | 6922 | 0.080 |
Why?
|
Coronary Vessel Anomalies | 1 | 2009 | 314 | 0.070 |
Why?
|
Autopsy | 2 | 2021 | 980 | 0.070 |
Why?
|
Learning | 1 | 2015 | 1587 | 0.070 |
Why?
|
Hospitalization | 2 | 2022 | 9632 | 0.070 |
Why?
|
Prospective Studies | 2 | 2022 | 50734 | 0.070 |
Why?
|
Cells, Cultured | 1 | 2021 | 20303 | 0.070 |
Why?
|
Middle Aged | 9 | 2022 | 215428 | 0.060 |
Why?
|
Mortality | 1 | 2015 | 2794 | 0.060 |
Why?
|
Tomography, X-Ray Computed | 3 | 2022 | 20307 | 0.060 |
Why?
|
Animals | 5 | 2021 | 170647 | 0.060 |
Why?
|
Diagnosis, Differential | 2 | 2015 | 13362 | 0.060 |
Why?
|
Female | 9 | 2021 | 377269 | 0.050 |
Why?
|
Atlases as Topic | 1 | 2021 | 235 | 0.050 |
Why?
|
Sensitivity and Specificity | 1 | 2015 | 14895 | 0.050 |
Why?
|
Pulmonary Artery | 2 | 2018 | 1895 | 0.050 |
Why?
|
Pulmonary Alveoli | 1 | 2022 | 731 | 0.050 |
Why?
|
Prognosis | 2 | 2020 | 29148 | 0.040 |
Why?
|
Advanced Cardiac Life Support | 1 | 2018 | 69 | 0.040 |
Why?
|
Macrophages, Alveolar | 1 | 2021 | 441 | 0.040 |
Why?
|
Organizational Objectives | 1 | 2020 | 436 | 0.040 |
Why?
|
Femoral Vein | 1 | 2018 | 161 | 0.040 |
Why?
|
Smad3 Protein | 1 | 2018 | 196 | 0.040 |
Why?
|
Coronary Vessels | 1 | 2009 | 2941 | 0.040 |
Why?
|
Plasma Cells | 1 | 2021 | 597 | 0.040 |
Why?
|
Aged | 6 | 2021 | 162592 | 0.040 |
Why?
|
Heart | 1 | 2009 | 4281 | 0.040 |
Why?
|
Antigens, Differentiation | 1 | 2019 | 970 | 0.040 |
Why?
|
Adult | 5 | 2021 | 212298 | 0.040 |
Why?
|
Mice | 2 | 2021 | 80950 | 0.040 |
Why?
|
Efficiency, Organizational | 1 | 2020 | 697 | 0.040 |
Why?
|
Bundle-Branch Block | 1 | 2016 | 276 | 0.030 |
Why?
|
Safety Management | 1 | 2020 | 775 | 0.030 |
Why?
|
Systems Biology | 1 | 2018 | 494 | 0.030 |
Why?
|
Needs Assessment | 1 | 2020 | 1148 | 0.030 |
Why?
|
Europe | 1 | 2020 | 3365 | 0.030 |
Why?
|
Program Development | 1 | 2020 | 1331 | 0.030 |
Why?
|
Fatal Outcome | 1 | 2018 | 1891 | 0.030 |
Why?
|
Heart Defects, Congenital | 1 | 2009 | 4264 | 0.030 |
Why?
|
Cardiovascular Diseases | 1 | 2018 | 14054 | 0.030 |
Why?
|
Face | 1 | 2018 | 965 | 0.030 |
Why?
|
Back Pain | 1 | 2016 | 541 | 0.030 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2019 | 4012 | 0.030 |
Why?
|
Heart Failure | 1 | 2015 | 9901 | 0.030 |
Why?
|
Rats | 2 | 2019 | 25068 | 0.030 |
Why?
|
Pulmonary Emphysema | 1 | 2016 | 672 | 0.030 |
Why?
|
Exercise Test | 1 | 2018 | 2113 | 0.020 |
Why?
|
Fibroblasts | 1 | 2021 | 4312 | 0.020 |
Why?
|
Occupational Exposure | 1 | 2020 | 1774 | 0.020 |
Why?
|
Radiography, Thoracic | 1 | 2016 | 1340 | 0.020 |
Why?
|
Heart Arrest | 1 | 2018 | 1346 | 0.020 |
Why?
|
Chest Pain | 1 | 2016 | 1091 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2020 | 6830 | 0.020 |
Why?
|
Retrospective Studies | 3 | 2021 | 71151 | 0.020 |
Why?
|
Fistula | 1 | 2009 | 213 | 0.020 |
Why?
|
Massachusetts | 1 | 2020 | 8754 | 0.020 |
Why?
|
Survival Analysis | 1 | 2020 | 10603 | 0.020 |
Why?
|
Rats, Sprague-Dawley | 1 | 2018 | 8581 | 0.020 |
Why?
|
Macrophages | 1 | 2021 | 5774 | 0.020 |
Why?
|
Acute Disease | 1 | 2016 | 7201 | 0.020 |
Why?
|
Analgesics, Opioid | 1 | 2021 | 3301 | 0.020 |
Why?
|
Protein Binding | 1 | 2018 | 9694 | 0.020 |
Why?
|
Imaging, Three-Dimensional | 1 | 2018 | 4003 | 0.020 |
Why?
|
Disease Progression | 1 | 2022 | 13298 | 0.020 |
Why?
|
Hedgehog Proteins | 1 | 2009 | 767 | 0.020 |
Why?
|
Echocardiography | 1 | 2016 | 5123 | 0.020 |
Why?
|
T-Lymphocytes | 1 | 2021 | 10475 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2021 | 21874 | 0.010 |
Why?
|
Electrocardiography | 1 | 2016 | 6390 | 0.010 |
Why?
|
Risk Factors | 2 | 2020 | 70264 | 0.010 |
Why?
|
Inflammation | 1 | 2021 | 9948 | 0.010 |
Why?
|
Myocytes, Cardiac | 1 | 2009 | 1632 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 2019 | 12468 | 0.010 |
Why?
|
Receptors, Cell Surface | 1 | 2009 | 2917 | 0.010 |
Why?
|
Cohort Studies | 1 | 2021 | 39650 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2021 | 58752 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2009 | 13351 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2009 | 15286 | 0.010 |
Why?
|
United States | 1 | 2020 | 67177 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2009 | 23044 | 0.010 |
Why?
|
Concepts
(161)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(101)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_